Skip to main content

Table 6 The parameters of RILD patients before and after SBRT

From: Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm)

  ALP Bilirubin ALT AST ALB Ascites
Pre- Post- Pre- Post- Pre- Post- Pre- Post- Pre- Post- Pre- Post-
Classic RILD 131 341 9.8 9.5 28 39 32 32 43 36
67 80 12.8 9.9 43 34 43 29 46 35 ++
59 327 14.5 8.4 13 18 16 29 44 41 +
113 362 7.8 8.2 16 31 46 38 42 44
Non-Classic RILD 67 136 22.7 51.6 30 608 28 363 36 40
79 81 18.5 35.6 28 17 37 42 39 34
79 116 12 16 22 214 27 223 34 33
73 147 26.1 51.4 34 749 42 678 36 32 +
\